Skip to main content
logo
Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
5.85
+0.22 (3.91%)
At close: Feb 18, 2026, 4:00 PM EST
5.73
-0.12 (-2.02%)
After-hours: Feb 18, 2026, 5:33 PM EST

Candel Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
---0.130.130.13
Cost of Revenue
23.0718.2323.5920.3514.59-
Gross Profit
-23.07-18.23-23.59-20.22-14.470.13
Selling, General & Admin
16.7614.414.4114.511.265.99
Research & Development
-----7.94
Operating Expenses
16.7614.414.4114.511.2613.94
Operating Income
-39.83-32.63-38-34.72-25.73-13.81
Interest Expense
-1.09-2.09-2.6-1.71-0.05-
Interest & Investment Income
3.11.092.081.22-0.11
Other Non Operating Income (Expenses)
15.89-20.80.9716.42-10.81-3.98
EBT Excluding Unusual Items
-21.94-54.44-37.55-18.79-36.59-17.68
Merger & Restructuring Charges
-0.7-0.7----
Asset Writedown
-0.12-0.04-0.39---
Other Unusual Items
----0.46-
Pretax Income
-22.76-55.18-37.94-18.79-36.12-17.68
Net Income
-22.76-55.18-37.94-18.79-36.12-17.68
Net Income to Common
-22.76-55.18-37.94-18.79-36.12-17.68
Shares Outstanding (Basic)
483229291912
Shares Outstanding (Diluted)
483229291912
Shares Change (YoY)
60.30%9.47%0.39%52.72%62.49%0.70%
EPS (Basic)
-0.47-1.74-1.31-0.65-1.91-1.52
EPS (Diluted)
-0.47-1.74-1.31-0.65-1.91-1.52
Free Cash Flow
-33.74-27.04-34.7-32.72-24.05-10.55
Free Cash Flow Per Share
-0.70-0.85-1.20-1.14-1.27-0.91
Gross Margin
-----100.00%
Operating Margin
----27777.60%-20580.80%-11048.00%
Profit Margin
----15035.20%-28899.20%-14144.00%
Free Cash Flow Margin
----26172.80%-19242.40%-8437.60%
EBITDA
-38.9-31.64-37.04-33.94-25.49-13.72
D&A For EBITDA
0.930.990.960.780.230.09
EBIT
-39.83-32.63-38-34.72-25.73-13.81
Updated Nov 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q